TRVITrevi Therapeutics, Inc.
- Market cap
- $1.80B
- as of 2026-10-23
- Latest close
- $12.61
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-12
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Heffernan Michael Thomas | Sep 15 | Sep 17 | M | 18,421 | $3.04 | $56,000 | 24,772 | Yes | Form 4 |
| Heffernan Michael Thomas | Sep 15 | Sep 17 | S | 18,321 | $15.09 | Sale −$276,464 | 6,451 | Yes | Form 4 |
| Heffernan Michael Thomas | Sep 15 | Sep 17 | S | 100 | $15.88 | Sale −$1,588 | 6,351 | Yes | Form 4 |
| Heffernan Michael Thomas | Sep 15 | Sep 17 | M | 21,052 | $3.33 | $70,103 | 27,403 | Yes | Form 4 |
| Heffernan Michael Thomas | Sep 15 | Sep 17 | S | 20,952 | $15.09 | Sale −$316,166 | 6,451 | Yes | Form 4 |
| Heffernan Michael Thomas | Sep 15 | Sep 17 | S | 100 | $15.88 | Sale −$1,588 | 6,351 | Yes | Form 4 |
| Heffernan Michael Thomas | Sep 15 | Sep 17 | M · derivative | 18,421 | $3.04 | $56,000 | not reported | Yes | Form 4 |
| Heffernan Michael Thomas | Sep 15 | Sep 17 | M · derivative | 21,052 | $3.33 | $70,103 | not reported | Yes | Form 4 |
| Heffernan Michael Thomas | Jun 3 | Jun 4 | A · derivative | 35,000 | $13.45 | $470,750 | 35,000 | No | Form 4 |
| Colangelo Dominick | Jun 3 | Jun 4 | A · derivative | 35,000 | $13.45 | $470,750 | 35,000 | No | Form 4 |
| Vanlent Anne | Jun 3 | Jun 4 | A · derivative | 35,000 | $13.45 | $470,750 | 35,000 | No | Form 4 |
| Meeker David P | Jun 3 | Jun 4 | A · derivative | 35,000 | $13.45 | $470,750 | 35,000 | No | Form 4 |
| Mathers Edward T | Jun 3 | Jun 4 | A · derivative | 35,000 | $13.45 | $470,750 | 35,000 | No | Form 4 |
| Simon FarrellChief Commercial Officer | Feb 19 | Feb 20 | A · derivative | 160,000 | $10.56 | $1,689,600 | 160,000 | No | Form 4 |
| Good Jennifer LPresident & CEO | Feb 19 | Feb 20 | A · derivative | 675,000 | $10.56 | $7,128,000 | 675,000 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Feb 19 | Feb 20 | A · derivative | 85,000 | $10.56 | $897,600 | 85,000 | No | Form 4 |
| Galletta ChristopherSee Remarks | Feb 19 | Feb 20 | A · derivative | 35,000 | $10.56 | $369,600 | 35,000 | No | Form 4 |
| Cassella James VChief Development Officer | Feb 19 | Feb 20 | A · derivative | 215,000 | $10.56 | $2,270,400 | 215,000 | No | Form 4 |
| Hastings David CChief Financial Officer | Jan 8 | Jan 12 | A · derivative | 375,000 | $11.21 | $4,203,750 | 375,000 | No | Form 4 |
| Galletta ChristopherSee Remarks | Dec 2, 2025 | Dec 3, 2025 | M | 4,225 | $0.51 | $2,155 | 26,095 | No | Form 4 |
| Galletta ChristopherSee Remarks | Dec 2, 2025 | Dec 3, 2025 | M · derivative | 4,225 | $0.51 | $2,155 | 15,775 | No | Form 4 |
| Meeker David P | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 45,000 | $6.25 | $281,250 | 45,000 | No | Form 4 |
| Vanlent Anne | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 45,000 | $6.25 | $281,250 | 45,000 | No | Form 4 |
| Heffernan Michael Thomas | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 45,000 | $6.25 | $281,250 | 45,000 | No | Form 4 |
| Colangelo Dominick | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 45,000 | $6.25 | $281,250 | 45,000 | No | Form 4 |
| Mathers Edward T | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 45,000 | $6.25 | $281,250 | 45,000 | No | Form 4 |
| Good Jennifer LPresident & CEO | May 31, 2025 | Jun 3, 2025 | A · derivative | 102,000 | $2.38 | $242,760 | 156,400 | No | Form 4 |
| Simon FarrellChief Commercial Officer | May 31, 2025 | Jun 3, 2025 | A · derivative | 72,000 | $2.38 | $171,360 | 110,400 | No | Form 4 |
| Delfini LisaChief Financial Officer | May 31, 2025 | Jun 3, 2025 | A · derivative | 72,000 | $2.38 | $171,360 | 110,400 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | May 31, 2025 | Jun 3, 2025 | A · derivative | 60,000 | $2.38 | $142,800 | 92,000 | No | Form 4 |
| Galletta ChristopherSee Remarks | May 31, 2025 | Jun 3, 2025 | A · derivative | 8,550 | $2.38 | $20,349 | 13,110 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Mar 25, 2025 | Mar 26, 2025 | M | 2,631 | $1.43 | $3,762 | 224,004 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Mar 25, 2025 | Mar 26, 2025 | S | 2,631 | $6.60 | Sale −$17,365 | 221,373 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Mar 25, 2025 | Mar 26, 2025 | M · derivative | 2,631 | $1.43 | $3,762 | not reported | No | Form 4 |
| Good Jennifer LPresident & CEO | Mar 21, 2025 | Mar 25, 2025 | M | 5,263 | $1.43 | $7,526 | 218,576 | No | Form 4 |
| Good Jennifer LPresident & CEO | Mar 21, 2025 | Mar 25, 2025 | S | 5,263 | $6.58 | Sale −$34,631 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | Mar 21, 2025 | Mar 25, 2025 | M · derivative | 5,263 | $1.43 | $7,526 | not reported | No | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 17,500 | $3.21 | $56,175 | 63,150 | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 63,813 | $3.91 | $249,509 | 126,963 | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 31,250 | $0.51 | $15,938 | 158,213 | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | S | 76,963 | $6.73 | Sale −$517,961 | 81,250 | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | S | 4,350 | $7.15 | Sale −$31,103 | 76,900 | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 38,400 | $2.38 | $91,392 | 38,400 | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 17,500 | $3.21 | $56,175 | not reported | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 63,813 | $3.91 | $249,509 | 11,187 | Yes | Form 4 |
| Simon FarrellChief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 31,250 | $0.51 | $15,938 | 18,750 | Yes | Form 4 |
| Galletta ChristopherSee Remarks | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 4,560 | $2.38 | $10,853 | 4,560 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 32,000 | $2.38 | $76,160 | 32,000 | No | Form 4 |
| Delfini LisaChief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 38,400 | $2.38 | $91,392 | 38,400 | No | Form 4 |
| Good Jennifer LPresident & CEO | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 54,400 | $2.38 | $129,472 | 54,400 | No | Form 4 |
| Galletta ChristopherSee Remarks | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 41,000 | $4.22 | $173,020 | 41,000 | No | Form 4 |
| Good Jennifer LPresident & CEO | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 811,000 | $4.22 | $3,422,420 | 811,000 | No | Form 4 |
| Delfini LisaChief Financial Officer | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 225,500 | $4.22 | $951,610 | 225,500 | No | Form 4 |
| Simon FarrellChief Commercial Officer | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 225,500 | $4.22 | $951,610 | 225,500 | No | Form 4 |
| Cassella James VChief Development Officer | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 257,500 | $4.22 | $1,086,650 | 257,500 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 116,000 | $4.22 | $489,520 | 116,000 | No | Form 4 |
| Delfini LisaChief Financial Officer | Jan 8, 2025 | Jan 10, 2025 | M | 5,000 | $0.51 | $2,550 | 64,660 | No | Form 4 |
| Delfini LisaChief Financial Officer | Jan 8, 2025 | Jan 10, 2025 | M · derivative | 5,000 | $0.51 | $2,550 | 42,125 | No | Form 4 |
| Delfini LisaChief Financial Officer | Jan 7, 2025 | Jan 10, 2025 | M | 1,000 | $0.51 | $510 | 59,660 | No | Form 4 |
| Delfini LisaChief Financial Officer | Jan 7, 2025 | Jan 10, 2025 | M · derivative | 1,000 | $0.51 | $510 | 47,125 | No | Form 4 |
| Galletta ChristopherSee Remarks | Dec 13, 2024 | Dec 17, 2024 | M | 15,000 | $0.51 | $7,650 | 19,935 | No | Form 4 |
| Galletta ChristopherSee Remarks | Dec 13, 2024 | Dec 17, 2024 | M · derivative | 15,000 | $0.51 | $7,650 | 20,000 | No | Form 4 |
| Cassella James VChief Development Officer | Sep 30, 2024 | Oct 1, 2024 | A · derivative | 400,000 | $3.34 | $1,336,000 | 400,000 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 9, 2024 | Sep 9, 2024 | M | 1,840 | $1.43 | $2,631 | 215,153 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 9, 2024 | Sep 9, 2024 | S | 1,840 | $3.04 | Sale −$5,594 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 9, 2024 | Sep 9, 2024 | M · derivative | 1,840 | $1.43 | $2,631 | not reported | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 6, 2024 | Sep 9, 2024 | M | 4,219 | $1.43 | $6,033 | 217,532 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 6, 2024 | Sep 9, 2024 | S | 4,219 | $3.03 | Sale −$12,784 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 6, 2024 | Sep 9, 2024 | M · derivative | 4,219 | $1.43 | $6,033 | 1,840 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 5, 2024 | Sep 5, 2024 | M | 40,277 | $1.43 | $57,596 | 253,590 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 5, 2024 | Sep 5, 2024 | S | 40,277 | $3.11 | Sale −$125,261 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 5, 2024 | Sep 5, 2024 | M · derivative | 40,277 | $1.43 | $57,596 | 6,059 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 4, 2024 | Sep 5, 2024 | M | 10,981 | $1.43 | $15,703 | 224,294 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 4, 2024 | Sep 5, 2024 | S | 10,981 | $3.02 | Sale −$33,163 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 4, 2024 | Sep 5, 2024 | M · derivative | 10,981 | $1.43 | $15,703 | 46,336 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 3, 2024 | Sep 5, 2024 | M | 3,863 | $1.43 | $5,524 | 217,176 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 3, 2024 | Sep 5, 2024 | S | 3,863 | $3.02 | Sale −$11,666 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | Sep 3, 2024 | Sep 5, 2024 | M · derivative | 3,863 | $1.43 | $5,524 | 57,317 | No | Form 4 |
| Meeker David P | Aug 27, 2024 | Aug 29, 2024 | M | 4,555 | $1.43 | $6,514 | 357,044 | No | Form 4 |
| Meeker David P | Aug 27, 2024 | Aug 29, 2024 | S | 4,555 | $2.93 | Sale −$13,346 | 352,489 | No | Form 4 |
| Meeker David P | Aug 27, 2024 | Aug 29, 2024 | M · derivative | 4,555 | $1.43 | $6,514 | not reported | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 19, 2024 | Aug 21, 2024 | M | 16,496 | $1.43 | $23,589 | 236,811 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 19, 2024 | Aug 21, 2024 | S | 16,496 | $2.96 | Sale −$48,828 | 220,315 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 19, 2024 | Aug 21, 2024 | M · derivative | 16,496 | $1.43 | $23,589 | not reported | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 16, 2024 | Aug 16, 2024 | M | 18,660 | $1.43 | $26,684 | 238,975 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 16, 2024 | Aug 16, 2024 | S | 18,660 | $2.76 | Sale −$51,502 | 220,315 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 16, 2024 | Aug 16, 2024 | M · derivative | 18,660 | $1.43 | $26,684 | 16,496 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 15, 2024 | Aug 16, 2024 | M | 12,745 | $1.43 | $18,225 | 233,060 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 15, 2024 | Aug 16, 2024 | S | 12,745 | $2.79 | Sale −$35,559 | 220,315 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 15, 2024 | Aug 16, 2024 | M · derivative | 12,745 | $1.43 | $18,225 | 35,156 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 14, 2024 | Aug 16, 2024 | M | 100 | $1.43 | $143 | 220,415 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 14, 2024 | Aug 16, 2024 | S | 100 | $2.75 | Sale −$275 | 220,315 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Aug 14, 2024 | Aug 16, 2024 | M · derivative | 100 | $1.43 | $143 | 47,901 | No | Form 4 |
| Colangelo Dominick | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 30,000 | $2.77 | $83,100 | 30,000 | No | Form 4 |
| Meeker David P | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 30,000 | $2.77 | $83,100 | 30,000 | No | Form 4 |
| Heffernan Michael Thomas | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 30,000 | $2.77 | $83,100 | 30,000 | No | Form 4 |
| Cassella James V | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 30,000 | $2.77 | $83,100 | 30,000 | No | Form 4 |
| Vanlent Anne | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 30,000 | $2.77 | $83,100 | 30,000 | No | Form 4 |
| Mathers Edward T | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 30,000 | $2.77 | $83,100 | 30,000 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | May 29, 2024 | May 31, 2024 | M | 59,354 | $2.19 | $129,985 | 267,801 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | May 29, 2024 | May 31, 2024 | S | 53,368 | $2.55 | Sale −$136,088 | 214,433 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | May 29, 2024 | May 31, 2024 | M · derivative | 59,354 | $2.19 | $129,985 | not reported | No | Form 4 |
| Delfini LisaChief Financial Officer | May 22, 2024 | May 24, 2024 | M | 16,043 | $0.51 | $8,182 | 57,629 | No | Form 4 |
| Delfini LisaChief Financial Officer | May 22, 2024 | May 24, 2024 | S | 4,350 | $2.64 | Sale −$11,484 | 53,279 | No | Form 4 |
| Delfini LisaChief Financial Officer | May 22, 2024 | May 24, 2024 | M · derivative | 16,043 | $0.51 | $8,182 | 48,125 | No | Form 4 |
| Good Jennifer LPresident & CEO | May 20, 2024 | May 22, 2024 | M | 25,037 | $2.19 | $54,831 | 238,350 | No | Form 4 |
| Good Jennifer LPresident & CEO | May 20, 2024 | May 22, 2024 | S | 25,037 | $2.86 | Sale −$71,606 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | May 20, 2024 | May 22, 2024 | M · derivative | 25,037 | $2.19 | $54,831 | 33,189 | No | Form 4 |
| Good Jennifer LPresident & CEO | May 10, 2024 | May 14, 2024 | M | 4,578 | $2.19 | $10,026 | 217,891 | No | Form 4 |
| Good Jennifer LPresident & CEO | May 10, 2024 | May 14, 2024 | S | 4,578 | $2.90 | Sale −$13,276 | 213,313 | No | Form 4 |
| Good Jennifer LPresident & CEO | May 10, 2024 | May 14, 2024 | M · derivative | 4,578 | $2.19 | $10,026 | 58,226 | No | Form 4 |
| Delfini LisaChief Financial Officer | Feb 15, 2024 | Feb 16, 2024 | A · derivative | 175,000 | $2.38 | $416,500 | 175,000 | No | Form 4 |
| Sciascia ThomasChief Scientific Officer | Feb 15, 2024 | Feb 16, 2024 | A · derivative | 150,000 | $2.38 | $357,000 | 150,000 | No | Form 4 |
| Good Jennifer LPresident & CEO | Feb 15, 2024 | Feb 16, 2024 | A · derivative | 630,000 | $2.38 | $1,499,400 | 630,000 | No | Form 4 |
| Clark David JChief Medical Officer | Feb 15, 2024 | Feb 16, 2024 | A · derivative | 175,000 | $2.38 | $416,500 | 175,000 | No | Form 4 |
| Simon FarrellChief Commercial Officer | Feb 15, 2024 | Feb 16, 2024 | A · derivative | 175,000 | $2.38 | $416,500 | 175,000 | No | Form 4 |
| Galletta ChristopherSee Remarks | Feb 15, 2024 | Feb 16, 2024 | A · derivative | 28,500 | $2.38 | $67,830 | 28,500 | No | Form 4 |
| Delfini LisaChief Financial Officer | Oct 11, 2023 | Oct 12, 2023 | M | 2,292 | $0.51 | $1,169 | 36,686 | Yes | Form 4 |
| Delfini LisaChief Financial Officer | Oct 11, 2023 | Oct 12, 2023 | S | 785 | $2.02 | Sale −$1,586 | 35,901 | Yes | Form 4 |
| Delfini LisaChief Financial Officer | Oct 11, 2023 | Oct 12, 2023 | M · derivative | 2,292 | $0.51 | $1,169 | 64,168 | Yes | Form 4 |